Showing results (81-90 of 203) with videos related to

Sort By:
Pageof 21
JAMA Pediatrics|December 16, 2014
Nonalcoholic fatty liver disease: a challenge for pediatriciansValerio Nobili, Naim Alkhouri, Anna Alisi, et al.
The Journal of Pediatrics|May 27, 2019
The Role of Genetic Predisposition, Programing During Fetal Life, Family Conditions, and Post-natal Diet in the Development of Pediatric Fatty Liver DiseaseAntonella Mosca, Valentina De Cosmi, Fabio Parazzini, et al.
Metabolites|January 26, 2024
Environment, Endocrine Disruptors, and Fatty Liver Disease Associated with Metabolic Dysfunction (MASLD)Antonella Mosca, Melania Manco, Maria Rita Braghini, et al.
Plos One|August 1, 2018
Expression of insulin-like growth factor I and its receptor in the liver of children with biopsy-proven NAFLDAnna Alisi, Valentina Pampanini, Cristiano De Stefanis, et al.
Diabetes & Metabolic Syndrome|September 25, 2025
Impact of diabetes on cellular connections: Pathological insights and emerging therapeutic targetsAbhinav Kanwal, Navjot Kanwar, Maya P Shetty, et al.
Pediatric Research|May 25, 2010
Severity of liver injury and atherogenic lipid profile in children with nonalcoholic fatty liver diseaseValerio Nobili, Naim Alkhouri, Andrea Bartuli, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 14, 2012
Combined paediatric NAFLD fibrosis index and transient elastography to predict clinically significant fibrosis in children with fatty liver diseaseNaim Alkhouri, Emad Sedki, Anna Alisi, et al.
Journal of Hepatology|August 9, 2012
Development and validation of a new histological score for pediatric non-alcoholic fatty liver diseaseNaim Alkhouri, Rita De Vito, Anna Alisi, et al.
Current Pediatric Reviews|April 4, 2023
Metabolic Associated Fatty Liver Disease in Children and Adolescents: Mechanisms of a Silent Epidemic and Therapeutic OptionsAntonella Mosca, Luca Della Volpe, Maria Rita Sartorelli, et al.
Clinical Therapeutics|July 22, 2008
Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot studyValerio Nobili, Melania Manco, Paolo Ciampalini, et al.
Pageof 21